HIV - how many affected, how many on ART, how many in the UK
37 mio worldwide, 21 mio on ART
101,200 affected in the UK
(70% of those on ART in the UK are undetectable)
What viral load in HIV is measured to be undetectable?
<20 copies / mm3(ml)
What type of virus is HIV and what does this mean?
it is an RNA retrovirus
it integrates itself into the hosts genome
lentivirus (from latin slow - long infection before symtoms of chronic infection seen)
Summarise the life cycle of HIV
1) virus binds to CD4 using gp120 (initial binding->conformational change). This causes releases of gp41 which causes fusion. (conformational change) receptors on CD4+ helper cells (also DCs and monocytes); also binds to CCR5 or CXCR4 chemokine co-receptors.
2) fuses with cell + uncoating
3) Reverse transcription from RNA -> DNA (via reverse transcriptase)
4) enters nucleus + integrates into genome via integrase
5) transcription -> nuclear export -> translation
6) assembly of viral products, Gag protein is infrastructural support for HIV.
7) budding, release and maturation of HIV
Immune response to HIV infection
innate:
- non specific activation of macrophages, NK cells and complement
- stimulation of dendritic cells via TLR
- release of cytokines and chemokines
adaptive:
- Neutralising antibodies: anti-gp41 IgM (first weeks) and anti-gp120 (later)
- non-neutralising antibodies: anti-p24 Gag IgG
- CD8+ cells kill infected CD4+ cells. They can also prevent HIV entry by producing chemokines (MIP-1a, MIP-1b, and RANTES which block co-receptors)
infected CD4+ cells are angergised.
Key immunological features of HIV-1 infection
CD4+ T-cell depletion
chronic immune activation
CD4 and cd8 T-cell exhaustion
disruption of lymph node architecture
loss of Ag specific humoral response
Why are quasi-species formed in HIV infection?
RT lacks proof reading mechanisms like DNA polymerases have and is therefore error prone
primary infection is usually with a single founder but quasi species develop rapidly
Issue - drug resistance mechanisms possible
What are the differences between HIV-1 and HIV-2?
HIV1&2 are endemic in West Africa, but HIV-2 is rarely found elsewhere -> HIV 1 is more common
higher viral loads seen in HIV-1-> easier transmission (MTCT is more likely in HIV-1, rare in HIV-2)
HIV-1 progresses to AIDS more rapidly and with higher incidence than HIV-2
HIV is the commonest cause of AIDS worldwide
3 Stages of HIV
1 - acute infection (70% people have flu like illness; during this time CD4+ T-cells drop and viral load is very high)
2 - asymptomatic (but progressive)
3 - AIDS
Untreated HIV - how long to progresss to AIDS?
typical progressors: 8-10 yrs
rapid progressors (10%) : 2-3 yrs
long term non-progressors (<5%) : show stable CD4 counts and no sx after 10 yrs
Important CD4 counts in HIV
400 - Kaposi’s sarcoma
300-350 - pulm TB
73 - MAC disease, PCP
MAC disease
seen in the context of low CD4 counts in HIV (<75)
mycobacterium avian complex
which tests are used to screen for and dx HIV?
screen: ELISA for HIV-Ab
confirm: HIV Ab via Western Blot
-> +ve test requires seroconversion therefore 45d post risk exposure (path guide says 10w)
HIV-1 RNA tests can be used when negative serology in the context of high clinical suspicion
In young children, what HIV test?
HIV-1 RNA +/- DNA
if less than 18m
serology not useful b/c passive transfer of Abs from mum
test to measure HIV viral load
PCR to detect viral RNA (very sensitive)
How is CD4+ T-cell count measured?
FACS flow cytometry
CD4+ count associated with AIDS
> 200 / mL of blood
resistance testing in HIV
phenotypic: viral replication measures in cell cultures under selective pressure of increasing concentration of antivirals - compared to wild type
genotypic: mutations determined by direct sequencing of the amplified HIV genome
HAART
highly active anti-retroviral therapy
2NRTIs + PI (or NNRTI)
Monitoring in HIV
usually every 6 months
viral load
CD4+ T-cell monitoring (not needed if CD4+ >350)
assess CVS, Osteoporosis risk + monitor LFTs, U&Es, renal, bone, lipid profile
Name drug classes for HIV
attachment inhibitors
fusion inhibitors
NRTI
NNRTI
NtRTI
Integrase inhibitors
protease inhibitors
Name a fusion inhibitor (ART)
enfuvirtide
Name an attachment inhibitor (ART)
maraviroc
Name NRTIs (ART)
zidovudine
abacavir
didanosine
emtricitabine
stavudine
lamavudine
zalcitabine
epzicom
combiner
trizivir